Pre-Treatment T-Cell Receptors (TCR) Repertoire in Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Single Agent Immunotherapy

被引：0
作者：
Abed, A. [1 ]
Calapre, L. [2 ]
Bowyer, S. [3 ]
Millward, M. [4 ]
Gray, E. [2 ]
机构：
[1] Linear Clin Res, Oncol, Nedlands, WA, Australia
[2] Edith Cowan Univ, Med Sci, Joondalup, WA, Australia
[3] Sir Charles Gairdner Hosp, Dept Med Oncol, Nedlands, WA, Australia
[4] Linear Clin Res, Nedlands, WA, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
T-CR repertoire; Non-small cell lung cancer; Immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA12.04
引用
收藏
页码：S870 / S870
页数：1
相关论文
共 50 条
  • [31] Clinical Predictive Markers of Response to Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
    Rhone, R.
    Raez, L.
    Dumais, K.
    Powery, H.
    Gentile, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1083 - S1083
  • [32] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [33] The role of ifosfamide in non-small cell lung cancer (NSCLC) treatment
    Manegold, K
    EXPERIMENTAL ONCOLOGY, 1996, 18 (01): : 69 - 72
  • [34] New perspectives in the treatment of non-small cell lung cancer (NSCLC)
    Brockmoeller, Juergen
    Junker, Klaus
    Multhoff, Gabriele
    ONKOLOGIE, 2006, 29 : 25 - 28
  • [35] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
  • [36] Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer
    Wang, Yadong
    Peng, Ling
    Zhao, Ming
    Xiong, Yuanyuan
    Xue, Jianchao
    Li, Bowen
    Huang, Zhicheng
    Liu, Xinyu
    Yang, Xiaoying
    Song, Yang
    Bing, Zhongxing
    Guo, Chao
    Tian, Zhenhuan
    Gao, Chao
    Cao, Lei
    Cao, Zhili
    Li, Ji
    Jiang, Xu
    Si, Xiaoyan
    Zhang, Li
    Li, Xiaoguang
    Zheng, Zhibo
    Song, Mengmeng
    Chen, Rongrong
    Lim, Wan-Teck
    Pavan, Alberto
    Romero, Atocha
    Liang, Naixin
    Yang, Huaxia
    Li, Shanqing
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (09) : 1936 - +
  • [37] Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer
    Galli, Giulia
    De Toma, Alessandro
    Pagani, Filippo
    Randon, Giovanni
    Trevisan, Benedetta
    Prelaj, Arsela
    Ferrara, Roberto
    Proto, Claudia
    Signorelli, Diego
    Ganzinelli, Monica
    Zilembo, Nicoletta
    de Braud, Filippo
    Garassino, Marina Chiara
    Lo Russo, Giuseppe
    LUNG CANCER, 2019, 137 : 38 - 42
  • [38] Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer
    Sepesi, Boris
    Cascone, Tina
    Chun, Stephen G.
    Altan, Mehmet
    Le, Xiuning
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 29 (04) : 555 - 569
  • [39] Impact of Age on Outcomes with Immunotherapy in Patients with Non-Small Cell Lung Cancer
    Lichtenstein, Morgan R. L.
    Nipp, Ryan D.
    Muzikansky, Alona
    Goodwin, Kelly
    Anderson, Danyon
    Newcomb, Richard A.
    Gainor, Justin F.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : 547 - 552
  • [40] Efficacy and Safety of Immunotherapy in Elderly Patients with Non-Small Cell Lung Cancer
    Galli, G.
    De Toma, A.
    Pagani, F.
    Randon, G.
    Trevisan, B.
    Prelaj, A.
    Ferrara, R.
    Proto, C.
    Signorelli, D.
    Ganzinelli, M.
    Zilembo, N.
    De Braud, F.
    Garassino, M.
    Lo Russo, G.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S454 - S454
12345